“

With a keen understanding of the MedTech landscape, I empower companies to navigate the complexities of M&A and portfolio moves, driving strategic growth in a rapidly evolving industry.

John Heinbigner

EY-Parthenon Partner, Life Sciences, Ernst & Young LLP

Experienced MedTech deals advisor. Husband and father of three growing and active young boys. Baseball fanatic.

Areas of focus
Transactions and Corporate Finance by EY-Parthenon
Strategy and Transactions
Strategy by EY-Parthenon
Private equity
Mergers and acquisitions
Life sciences
Office Minneapolis, MN, United States

As a partner with over 17 years of experience in the MedTech industry, John empowers Fortune 500 client executives and their M&A agenda.

John specializes in M&A-driven transformation, including buy-side diligence and carve-out transactions for strategics, and full enterprise sales for private equity clients.

John received a BBA in Accounting from Saint John’s University and an MBA from the University of Minnesota.

He is a member of the AHA Twin Cities board and a CPA licensed in Minnesota.

How John is building a better working world

John uses his deep experience in MedTech to advise clients on making smart M&A decisions so they can bring innovation to market and save patients’ lives.

John's latest thinking

    Contact John

    EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.